Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA To Adopt Cost-Effectiveness Role? Congress May Revisit Issue, Crawford Says

This article was originally published in The Pink Sheet Daily

Executive Summary

Medicare reform will link FDA more closely with CMS, which could necessitate FDA becoming more economically aware of approval decisions, Acting Commissioner Crawford says. FDAer envisions a relationship with CMS that is akin to a merger.

You may also be interested in...



FDA Mission Should Not Include Rx Cost Effectiveness, Rep. Allen Says

Comparative studies should be "untainted" by industry's influence, the Maine Democrat says. He urges full appropriation of funding to AHRQ under the new Medicare law.

FDA Mission Should Not Include Rx Cost Effectiveness, Rep. Allen Says

Comparative studies should be "untainted" by industry's influence, the Maine Democrat says. He urges full appropriation of funding to AHRQ under the new Medicare law.

Rx Cost-Effectiveness Research Is Government's Job, But Not FDA's, AMCP Says

AHRQ and NIH have role in carrying out post-approval drug research, but FDA's authority is limited to approving drugs based on safety and efficacy, Academy of Managed Care Pharmacy policy statement says.

Related Content

Topics

UsernamePublicRestriction

Register

LL1126093

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel